Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 2 |
GO:0005730 | nucleolus | 5 | 9 |
GO:0016020 | membrane | 2 | 5 |
GO:0030896 | checkpoint clamp complex | 3 | 9 |
GO:0032991 | protein-containing complex | 1 | 9 |
GO:0035861 | site of double-strand break | 3 | 2 |
GO:0043226 | organelle | 2 | 9 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043228 | non-membrane-bounded organelle | 3 | 9 |
GO:0043229 | intracellular organelle | 3 | 9 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 9 |
GO:0090734 | site of DNA damage | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
GO:0140513 | nuclear protein-containing complex | 2 | 9 |
Related structures:
AlphaFold database: Q4QBE5
Term | Name | Level | Count |
---|---|---|---|
GO:0000075 | cell cycle checkpoint signaling | 4 | 9 |
GO:0000076 | DNA replication checkpoint signaling | 6 | 2 |
GO:0000077 | DNA damage checkpoint signaling | 5 | 9 |
GO:0000723 | telomere maintenance | 5 | 2 |
GO:0000724 | double-strand break repair via homologous recombination | 7 | 2 |
GO:0000725 | recombinational repair | 6 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006259 | DNA metabolic process | 4 | 2 |
GO:0006281 | DNA repair | 5 | 2 |
GO:0006289 | nucleotide-excision repair | 6 | 2 |
GO:0006302 | double-strand break repair | 6 | 2 |
GO:0006310 | DNA recombination | 5 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0006950 | response to stress | 2 | 9 |
GO:0006974 | DNA damage response | 4 | 9 |
GO:0006996 | organelle organization | 4 | 2 |
GO:0007093 | mitotic cell cycle checkpoint signaling | 4 | 2 |
GO:0007165 | signal transduction | 2 | 9 |
GO:0007346 | regulation of mitotic cell cycle | 5 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009987 | cellular process | 1 | 9 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 7 | 2 |
GO:0010564 | regulation of cell cycle process | 5 | 9 |
GO:0010948 | negative regulation of cell cycle process | 6 | 9 |
GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 8 | 2 |
GO:0016043 | cellular component organization | 3 | 2 |
GO:0022402 | cell cycle process | 2 | 2 |
GO:0022414 | reproductive process | 1 | 2 |
GO:0031570 | DNA integrity checkpoint signaling | 5 | 9 |
GO:0031573 | mitotic intra-S DNA damage checkpoint signaling | 7 | 2 |
GO:0032200 | telomere organization | 6 | 2 |
GO:0033313 | meiotic cell cycle checkpoint signaling | 3 | 2 |
GO:0033314 | mitotic DNA replication checkpoint signaling | 6 | 2 |
GO:0033554 | cellular response to stress | 3 | 9 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0035556 | intracellular signal transduction | 3 | 9 |
GO:0042770 | signal transduction in response to DNA damage | 4 | 9 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 2 |
GO:0044773 | mitotic DNA damage checkpoint signaling | 6 | 2 |
GO:0044774 | mitotic DNA integrity checkpoint signaling | 5 | 2 |
GO:0044778 | meiotic DNA integrity checkpoint signaling | 4 | 2 |
GO:0044818 | mitotic G2/M transition checkpoint | 5 | 2 |
GO:0045786 | negative regulation of cell cycle | 5 | 9 |
GO:0045930 | negative regulation of mitotic cell cycle | 6 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0048519 | negative regulation of biological process | 3 | 9 |
GO:0048523 | negative regulation of cellular process | 4 | 9 |
GO:0050789 | regulation of biological process | 2 | 9 |
GO:0050794 | regulation of cellular process | 3 | 9 |
GO:0050896 | response to stimulus | 1 | 9 |
GO:0051276 | chromosome organization | 5 | 2 |
GO:0051716 | cellular response to stimulus | 2 | 9 |
GO:0051726 | regulation of cell cycle | 4 | 9 |
GO:0065007 | biological regulation | 1 | 9 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0071840 | cellular component organization or biogenesis | 2 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
GO:1901987 | regulation of cell cycle phase transition | 6 | 9 |
GO:1901988 | negative regulation of cell cycle phase transition | 7 | 9 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 6 | 2 |
GO:1901991 | negative regulation of mitotic cell cycle phase transition | 7 | 2 |
GO:1902749 | regulation of cell cycle G2/M phase transition | 7 | 2 |
GO:1902750 | negative regulation of cell cycle G2/M phase transition | 8 | 2 |
GO:1903046 | meiotic cell cycle process | 2 | 2 |
GO:1903047 | mitotic cell cycle process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003677 | DNA binding | 4 | 2 |
GO:0003684 | damaged DNA binding | 5 | 2 |
GO:0005488 | binding | 1 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 178 | 182 | PF00656 | 0.560 |
CLV_C14_Caspase3-7 | 205 | 209 | PF00656 | 0.515 |
CLV_C14_Caspase3-7 | 6 | 10 | PF00656 | 0.598 |
CLV_NRD_NRD_1 | 196 | 198 | PF00675 | 0.315 |
CLV_NRD_NRD_1 | 214 | 216 | PF00675 | 0.348 |
CLV_NRD_NRD_1 | 283 | 285 | PF00675 | 0.360 |
CLV_NRD_NRD_1 | 308 | 310 | PF00675 | 0.339 |
CLV_PCSK_KEX2_1 | 196 | 198 | PF00082 | 0.315 |
CLV_PCSK_KEX2_1 | 214 | 216 | PF00082 | 0.358 |
CLV_PCSK_KEX2_1 | 218 | 220 | PF00082 | 0.362 |
CLV_PCSK_KEX2_1 | 308 | 310 | PF00082 | 0.339 |
CLV_PCSK_PC1ET2_1 | 218 | 220 | PF00082 | 0.360 |
CLV_PCSK_PC7_1 | 214 | 220 | PF00082 | 0.348 |
CLV_PCSK_SKI1_1 | 215 | 219 | PF00082 | 0.365 |
CLV_PCSK_SKI1_1 | 223 | 227 | PF00082 | 0.379 |
CLV_PCSK_SKI1_1 | 275 | 279 | PF00082 | 0.342 |
CLV_PCSK_SKI1_1 | 308 | 312 | PF00082 | 0.313 |
CLV_PCSK_SKI1_1 | 8 | 12 | PF00082 | 0.364 |
DEG_APCC_DBOX_1 | 113 | 121 | PF00400 | 0.598 |
DEG_APCC_DBOX_1 | 154 | 162 | PF00400 | 0.515 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.501 |
DOC_CKS1_1 | 192 | 197 | PF01111 | 0.567 |
DOC_CYCLIN_yCln2_LP_2 | 190 | 193 | PF00134 | 0.542 |
DOC_MAPK_gen_1 | 218 | 228 | PF00069 | 0.598 |
DOC_MAPK_gen_1 | 308 | 315 | PF00069 | 0.539 |
DOC_MAPK_gen_1 | 8 | 16 | PF00069 | 0.594 |
DOC_MAPK_MEF2A_6 | 155 | 162 | PF00069 | 0.560 |
DOC_MAPK_MEF2A_6 | 308 | 315 | PF00069 | 0.519 |
DOC_MAPK_NFAT4_5 | 308 | 316 | PF00069 | 0.539 |
DOC_PP1_RVXF_1 | 33 | 39 | PF00149 | 0.560 |
DOC_PP2B_LxvP_1 | 148 | 151 | PF13499 | 0.598 |
DOC_PP2B_LxvP_1 | 190 | 193 | PF13499 | 0.555 |
DOC_PP4_FxxP_1 | 133 | 136 | PF00568 | 0.536 |
DOC_USP7_MATH_1 | 129 | 133 | PF00917 | 0.570 |
DOC_USP7_MATH_1 | 179 | 183 | PF00917 | 0.591 |
DOC_USP7_MATH_1 | 227 | 231 | PF00917 | 0.503 |
DOC_USP7_UBL2_3 | 4 | 8 | PF12436 | 0.554 |
DOC_WW_Pin1_4 | 146 | 151 | PF00397 | 0.598 |
DOC_WW_Pin1_4 | 191 | 196 | PF00397 | 0.567 |
LIG_14-3-3_CanoR_1 | 2 | 8 | PF00244 | 0.598 |
LIG_14-3-3_CanoR_1 | 241 | 245 | PF00244 | 0.560 |
LIG_14-3-3_CanoR_1 | 275 | 280 | PF00244 | 0.583 |
LIG_14-3-3_CanoR_1 | 288 | 296 | PF00244 | 0.468 |
LIG_14-3-3_CanoR_1 | 30 | 39 | PF00244 | 0.572 |
LIG_14-3-3_CanoR_1 | 53 | 59 | PF00244 | 0.599 |
LIG_Actin_WH2_2 | 161 | 178 | PF00022 | 0.560 |
LIG_APCC_ABBA_1 | 231 | 236 | PF00400 | 0.560 |
LIG_BIR_III_2 | 224 | 228 | PF00653 | 0.431 |
LIG_BIR_III_4 | 206 | 210 | PF00653 | 0.515 |
LIG_BIR_III_4 | 9 | 13 | PF00653 | 0.560 |
LIG_BRCT_BRCA1_1 | 181 | 185 | PF00533 | 0.598 |
LIG_BRCT_BRCA1_1 | 56 | 60 | PF00533 | 0.558 |
LIG_eIF4E_1 | 246 | 252 | PF01652 | 0.560 |
LIG_FHA_1 | 100 | 106 | PF00498 | 0.558 |
LIG_FHA_1 | 167 | 173 | PF00498 | 0.560 |
LIG_FHA_1 | 276 | 282 | PF00498 | 0.525 |
LIG_FHA_1 | 319 | 325 | PF00498 | 0.358 |
LIG_FHA_1 | 73 | 79 | PF00498 | 0.560 |
LIG_FHA_2 | 168 | 174 | PF00498 | 0.520 |
LIG_FHA_2 | 176 | 182 | PF00498 | 0.478 |
LIG_FHA_2 | 4 | 10 | PF00498 | 0.525 |
LIG_Integrin_isoDGR_2 | 112 | 114 | PF01839 | 0.398 |
LIG_LIR_Apic_2 | 130 | 136 | PF02991 | 0.509 |
LIG_LIR_Gen_1 | 243 | 252 | PF02991 | 0.560 |
LIG_LIR_Gen_1 | 283 | 293 | PF02991 | 0.560 |
LIG_LIR_Nem_3 | 243 | 249 | PF02991 | 0.525 |
LIG_LIR_Nem_3 | 283 | 289 | PF02991 | 0.560 |
LIG_LIR_Nem_3 | 56 | 61 | PF02991 | 0.454 |
LIG_PCNA_yPIPBox_3 | 320 | 330 | PF02747 | 0.442 |
LIG_Pex14_2 | 238 | 242 | PF04695 | 0.523 |
LIG_Pex14_2 | 286 | 290 | PF04695 | 0.560 |
LIG_SH2_NCK_1 | 246 | 250 | PF00017 | 0.560 |
LIG_SH2_SRC | 234 | 237 | PF00017 | 0.530 |
LIG_SH2_SRC | 326 | 329 | PF00017 | 0.438 |
LIG_SH2_SRC | 69 | 72 | PF00017 | 0.598 |
LIG_SH2_STAP1 | 234 | 238 | PF00017 | 0.563 |
LIG_SH2_STAT5 | 304 | 307 | PF00017 | 0.560 |
LIG_SH2_STAT5 | 326 | 329 | PF00017 | 0.438 |
LIG_SH3_2 | 192 | 197 | PF14604 | 0.515 |
LIG_SH3_3 | 186 | 192 | PF00018 | 0.560 |
LIG_SH3_3 | 214 | 220 | PF00018 | 0.598 |
LIG_SUMO_SIM_anti_2 | 247 | 253 | PF11976 | 0.602 |
LIG_SUMO_SIM_par_1 | 164 | 170 | PF11976 | 0.560 |
LIG_SUMO_SIM_par_1 | 277 | 283 | PF11976 | 0.526 |
LIG_TYR_ITIM | 244 | 249 | PF00017 | 0.523 |
LIG_TYR_ITIM | 59 | 64 | PF00017 | 0.431 |
LIG_UBA3_1 | 84 | 89 | PF00899 | 0.560 |
LIG_WRC_WIRS_1 | 168 | 173 | PF05994 | 0.560 |
MOD_CDK_SPK_2 | 191 | 196 | PF00069 | 0.587 |
MOD_CDK_SPxK_1 | 191 | 197 | PF00069 | 0.515 |
MOD_GlcNHglycan | 125 | 128 | PF01048 | 0.392 |
MOD_GlcNHglycan | 185 | 188 | PF01048 | 0.339 |
MOD_GlcNHglycan | 290 | 293 | PF01048 | 0.398 |
MOD_GlcNHglycan | 66 | 69 | PF01048 | 0.398 |
MOD_GSK3_1 | 175 | 182 | PF00069 | 0.583 |
MOD_GSK3_1 | 94 | 101 | PF00069 | 0.523 |
MOD_NEK2_1 | 166 | 171 | PF00069 | 0.548 |
MOD_NEK2_1 | 175 | 180 | PF00069 | 0.498 |
MOD_NEK2_1 | 280 | 285 | PF00069 | 0.573 |
MOD_NEK2_1 | 299 | 304 | PF00069 | 0.478 |
MOD_NEK2_1 | 3 | 8 | PF00069 | 0.525 |
MOD_NEK2_1 | 311 | 316 | PF00069 | 0.295 |
MOD_NEK2_1 | 39 | 44 | PF00069 | 0.562 |
MOD_NEK2_2 | 240 | 245 | PF00069 | 0.552 |
MOD_PKA_2 | 240 | 246 | PF00069 | 0.598 |
MOD_PKB_1 | 35 | 43 | PF00069 | 0.525 |
MOD_Plk_1 | 129 | 135 | PF00069 | 0.560 |
MOD_Plk_1 | 166 | 172 | PF00069 | 0.525 |
MOD_Plk_1 | 70 | 76 | PF00069 | 0.523 |
MOD_Plk_2-3 | 167 | 173 | PF00069 | 0.560 |
MOD_Plk_4 | 167 | 173 | PF00069 | 0.527 |
MOD_Plk_4 | 227 | 233 | PF00069 | 0.510 |
MOD_Plk_4 | 275 | 281 | PF00069 | 0.598 |
MOD_Plk_4 | 299 | 305 | PF00069 | 0.582 |
MOD_Plk_4 | 311 | 317 | PF00069 | 0.341 |
MOD_Plk_4 | 54 | 60 | PF00069 | 0.503 |
MOD_ProDKin_1 | 146 | 152 | PF00069 | 0.598 |
MOD_ProDKin_1 | 191 | 197 | PF00069 | 0.567 |
MOD_SUMO_for_1 | 244 | 247 | PF00179 | 0.560 |
TRG_DiLeu_BaEn_1 | 247 | 252 | PF01217 | 0.560 |
TRG_DiLeu_BaEn_2 | 166 | 172 | PF01217 | 0.501 |
TRG_ENDOCYTIC_2 | 246 | 249 | PF00928 | 0.501 |
TRG_ENDOCYTIC_2 | 61 | 64 | PF00928 | 0.601 |
TRG_ER_diArg_1 | 195 | 197 | PF00400 | 0.515 |
TRG_ER_diArg_1 | 213 | 215 | PF00400 | 0.558 |
TRG_ER_diArg_1 | 35 | 38 | PF00400 | 0.501 |
TRG_NES_CRM1_1 | 295 | 307 | PF08389 | 0.560 |
TRG_Pf-PMV_PEXEL_1 | 138 | 142 | PF00026 | 0.301 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I495 | Leptomonas seymouri | 63% | 99% |
A0A1X0NG57 | Trypanosomatidae | 35% | 100% |
A0A3S5H7B6 | Leishmania donovani | 95% | 100% |
A0A422NW79 | Trypanosoma rangeli | 40% | 100% |
A4HCP3 | Leishmania braziliensis | 84% | 100% |
A4I069 | Leishmania infantum | 95% | 100% |
E9AW32 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |